Recognition of the sequelae of neonatal bone and joint infections on the adjacent growth plates will encourage careful long-term observation of these children throughout growth. Technological advances have improved our abilities to diagnose and treat several of the neuromuscular diseases by allowing the treating physician to better understand the functional neuropathology. The refinement and proliferation of the motion analysis laboratory has put our appreciation of cerebral palsy on a more scientific basis. The recognition of latex allergy in the population of children with myelodysplasia will help us prevent or better treat these often significant reactions. Our continued exploration of the molecular basis of muscular dystrophy provides hope for future treatment capability.